Clinical Trial Update: Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin to prevent hepatocellular carcinoma in patients with liver cirrhosis; results have been posted and the study is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cirrhosis, Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-15